SSY Group (02005.HK) Receives Drug Production Registration Approvals for Three Drugs, All Deemed to Have Passed Consistency Evaluation

Zhitong Finance APP news, SSY Group (02005.HK) announced that the group has obtained drug production registration approvals from China's National Medical Products Administration for the following three products, all belonging to Class 4 chemical drugs and deemed to have passed consistency evaluation.